Distinct nasal and temporal variations in superficial vascular density as early indicators of diabetic retinopathy

• by Ziyan Ma, Fujuan Yu, Huan Li, Yang Liu, Bolin Deng, Yong Zeng

• January 3, 2026

Can Patients Switch to Biosimilar Aflibercept?

A 20-week INSIGHT extension suggests that switching from reference aflibercept to MYL-1701P maintained comparable safety, visual, and anatomic outcomes in patients with diabetic macular edema.

• by Andrea Surnit

• July 20, 2026

• 3 min

Side Effects: Context Is the Diagnosis

This week's research makes one thing clear: who someone is before they get sick — their relationships, their partner's health, the back of their eye — is doing a lot of work medicine is only beginning to account for.

• by Kerri Miller

• June 9, 2026

• 6 min

AI Falls Short on Differential Dx

New PrIME-LLM benchmark shows strong diagnostic accuracy but persistent gaps in clinical reasoning across 21 large language models

• by Kathryn Wighton

• April 13, 2026

• 4 min